more studies are needed to assess the adequacy of the UOVfor venous drainage of the uterus.There is significant interest in minimally invasive uterine procurementfor living donor uterine transplant, including bothrobotic and laparoscopic approaches. Obviously this wouldpresent clear benefits for the donor. Initial studies have investigatedthe possibility of a laparoscopic retrieval,20however, no current protocols in humans or animals haveever established a successful pregnancy using a minimallyinvasive approach.Ischemic TimesIschemia time is a factor in both living donor and deceaseddonor models, however it is a significant considerationin deceased donor protocols. In a deceased donor, the uterusis typically recovered following the removal of all other lifesavingorgans, which extends the initial ischemia time. Inaddition, the graft must be transported in ice-cold mediumto the awaiting recipient.While it is currently unknown whatthe optimal cold ischemia time is for uterine transplants, initialstudies have shown that the myometrium appears resistantto ischemic effects for at least six hours.21 A more recentstudy from France utilizing a deceased donor model foundthat based on histology and apoptosis assays, the uterus wasresistant to cold ischemia for up to 24 hours.18 However,because of the still relatively unknown effects of longer coldischemia time, geography must be considered in order toexpeditiously move the recovered organ to the recipient.3Because of the increased likelihood that the deceased donorwill not be in the same facility as the recipient, even withexpedited transport, the cold ischemia time will likely belonger in a deceased donor versus a living donor model. Thislonger ischemia time may be associated with diminished graftfunction or even increased risk of rejection.3